Variant report
Variant | esv3326849 |
---|---|
Chromosome Location | chr6:93286280-93299783 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-EPHA7-2 | chr6:93299040-93299050 | XLOC_005783 |
2 | lnc-EPHA7-2 | chr6:93299496-93299804 | XLOC_005783 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145080379 | chr6:93286473-93286474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs562644046 | chr6:93286497-93286498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs783848 | chr6:93286524-93286525 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs138800955 | chr6:93286585-93286586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112153683 | chr6:93286586-93286587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533919881 | chr6:93286591-93286592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs547504492 | chr6:93286607-93286608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567328589 | chr6:93286608-93286609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190440042 | chr6:93286616-93286617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536842018 | chr6:93286633-93286634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556764875 | chr6:93286661-93286662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114709916 | chr6:93286764-93286765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570799950 | chr6:93286766-93286767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140545316 | chr6:93286805-93286806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572403648 | chr6:93286823-93286824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541171220 | chr6:93286879-93286880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561058182 | chr6:93286916-93286917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574548100 | chr6:93286926-93286927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558940077 | chr6:93286976-93286977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2183002 | chr6:93286994-93286995 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs562669702 | chr6:93287089-93287090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531544206 | chr6:93287119-93287120 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183083414 | chr6:93287201-93287202 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200819053 | chr6:93287207-93287208 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187632523 | chr6:93287307-93287308 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564766449 | chr6:93287324-93287325 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527289866 | chr6:93287328-93287329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547368202 | chr6:93287374-93287375 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567391653 | chr6:93287376-93287377 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190902762 | chr6:93287393-93287394 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550141021 | chr6:93287434-93287435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570209283 | chr6:93287450-93287451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143798817 | chr6:93287480-93287481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs1590771 | chr6:93287540-93287541 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs565993627 | chr6:93287553-93287554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1590772 | chr6:93287566-93287567 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs371625212 | chr6:93287581-93287582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375258643 | chr6:93287591-93287592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574477517 | chr6:93287594-93287595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554517461 | chr6:93287595-93287596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574611232 | chr6:93287654-93287655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543497588 | chr6:93287657-93287658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556115108 | chr6:93287661-93287662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183973592 | chr6:93287691-93287692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544832989 | chr6:93287759-93287760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565185873 | chr6:93287793-93287794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187869694 | chr6:93287795-93287796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541043111 | chr6:93287860-93287861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560850784 | chr6:93287874-93287875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554821053 | chr6:93287924-93287925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuropathy | 19664229 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:93286400-93287800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr6:93286600-93287000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr6:93286600-93287800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr6:93286800-93287800 | Enhancers | HSMM | muscle |
5 | chr6:93286800-93287800 | Enhancers | NH-A | brain |
6 | chr6:93287000-93287400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr6:93287000-93287400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr6:93287000-93287400 | Enhancers | Hela-S3 | cervix |
9 | chr6:93287400-93288000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr6:93296000-93296200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr6:93296800-93300200 | Enhancers | Hela-S3 | cervix |